Show simple item record

dc.contributor.authorMasters, Grace A.
dc.contributor.authorBrenckle, Linda
dc.contributor.authorSankaran, Padma
dc.contributor.authorPerson, Sharina D.
dc.contributor.authorAllison, Jeroan J.
dc.contributor.authorMoore Simas, Tiffany A.
dc.contributor.authorKo, Jean Y.
dc.contributor.authorRobbins, Cheryl L.
dc.contributor.authorMarsh, Wendy K.
dc.contributor.authorByatt, Nancy
dc.date2022-08-11T08:10:31.000
dc.date.accessioned2022-08-23T17:11:47Z
dc.date.available2022-08-23T17:11:47Z
dc.date.issued2019-11-01
dc.date.submitted2020-01-02
dc.identifier.citation<p>Gen Hosp Psychiatry. 2019 Nov - Dec;61:53-59. doi: 10.1016/j.genhosppsych.2019.09.002. Epub 2019 Oct 22. <a href="https://doi.org/10.1016/j.genhosppsych.2019.09.002">Link to article on publisher's site</a></p>
dc.identifier.issn0163-8343 (Linking)
dc.identifier.doi10.1016/j.genhosppsych.2019.09.002
dc.identifier.pmid31710859
dc.identifier.urihttp://hdl.handle.net/20.500.14038/46360
dc.description.abstractOBJECTIVE: Bipolar disorder affects 2-8% of pregnant and postpartum women; untreated illness is associated with poor outcomes. This study aimed to describe bipolar disorder screening rates in obstetric settings and associated characteristics. METHOD: Women were recruited during pregnancy through three months postpartum from 14 obstetric clinics in Massachusetts. The Mood Disorder Questionnaire (MDQ) was used to screen for bipolar disorder; a subset previously diagnosed with bipolar was also examined. Differences in characteristics by screening outcome were tested using chi-square and t-tests. RESULTS: Of 574 participating women, 18.8% screened positive for bipolar disorder. Compared to those with negative, those with positive bipolar screens had 18.5-times the prevalence of positive substance use screens (11.1% vs. 0.6%, p < 0.001) and 3.4-times reported feeling they were not receiving adequate psychiatric help (24.0 vs. 7.0%, p < 0.001). Less than half of those with positive bipolar screens (42.0%) and 61.3% with pre-existing bipolar reported receiving current psychiatric care. CONCLUSIONS: Almost one in five perinatal women screened positive for bipolar disorder. Positive screenings were associated with comorbid substance use and low treatment rates. This study highlights the importance of screening for bipolar disorder during the perinatal period and the need for systematic approaches to ensure adequate assessment and follow-up. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier: NCT02760004.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=31710859&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1016/j.genhosppsych.2019.09.002
dc.subjectBipolar disorder
dc.subjectMood Disorder Questionnaire
dc.subjectPerinatal
dc.subjectUMCCTS funding
dc.subjectDiagnosis
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectMental and Social Health
dc.subjectObstetrics and Gynecology
dc.subjectPsychiatry
dc.subjectPsychiatry and Psychology
dc.subjectReproductive and Urinary Physiology
dc.subjectWomen's Health
dc.titlePositive screening rates for bipolar disorder in pregnant and postpartum women and associated risk factors
dc.typeJournal Article
dc.source.journaltitleGeneral hospital psychiatry
dc.source.volume61
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/psych_pp/920
dc.identifier.contextkey16101321
html.description.abstract<p>OBJECTIVE: Bipolar disorder affects 2-8% of pregnant and postpartum women; untreated illness is associated with poor outcomes. This study aimed to describe bipolar disorder screening rates in obstetric settings and associated characteristics.</p> <p>METHOD: Women were recruited during pregnancy through three months postpartum from 14 obstetric clinics in Massachusetts. The Mood Disorder Questionnaire (MDQ) was used to screen for bipolar disorder; a subset previously diagnosed with bipolar was also examined. Differences in characteristics by screening outcome were tested using chi-square and t-tests.</p> <p>RESULTS: Of 574 participating women, 18.8% screened positive for bipolar disorder. Compared to those with negative, those with positive bipolar screens had 18.5-times the prevalence of positive substance use screens (11.1% vs. 0.6%, p < 0.001) and 3.4-times reported feeling they were not receiving adequate psychiatric help (24.0 vs. 7.0%, p < 0.001). Less than half of those with positive bipolar screens (42.0%) and 61.3% with pre-existing bipolar reported receiving current psychiatric care.</p> <p>CONCLUSIONS: Almost one in five perinatal women screened positive for bipolar disorder. Positive screenings were associated with comorbid substance use and low treatment rates. This study highlights the importance of screening for bipolar disorder during the perinatal period and the need for systematic approaches to ensure adequate assessment and follow-up.</p> <p>CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov identifier: NCT02760004.</p>
dc.identifier.submissionpathpsych_pp/920
dc.contributor.departmentDepartment of Population and Quantitative Health Sciences
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.contributor.departmentDepartment of Obstetrics and Gynecology
dc.contributor.departmentImplementation Science and Practice Advances Research Center
dc.contributor.departmentDepartment of Psychiatry
dc.source.pages53-59


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record